Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0EYPZD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
AbDJ-ConjD
|
|||||
| Synonyms |
AbDJ ConjD
Click to Show/Hide
|
|||||
| Organization |
ADC Therapeutics SA; MedImmune LLC
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1-2
|
|||||
| Antibody Name |
Anti-CD22 mAb AbDJ
|
|||||
| Antigen Name |
B-cell receptor CD22 (CD22)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
AbDJ-ConjD linker
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines.
|
|||||